Digital Health Interventions for Diabetes: Everything to Gain and Nothing to Lose
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
IN BRIEF The traditional approach to integrating new therapies involves long, expensive roadmaps with evidence generation required for multiple stakeholders, most notably regulators and clinicians. More recently, new technologies such as insulin delivery systems and continuous glucose monitoring devices have become mainstream without complete clinical evidence being available when they were first introduced. There is tremendous enthusiasm from investors, industry, and people with diabetes regarding the potential of digital health to add value to diabetes care, and this enthusiasm exists despite a paucity of high-quality clinical evidence from traditional randomized clinical trials. Moreover, the potential of diabetes digital health technologies has been recognized by the U.S. Food and Drug Administration and other regulators, who are changing their approaches to allow easier, earlier access to diabetes software and devices. This wager that digital health will add value makes sense.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Health App Use Among US Mobile Phone Owners: A National Survey
Krebs, P., & Duncan, D. T. (2015) · JMIR mHealth and uHealth · doi:10.2196/mhealth.4924 · Cited by 1,274 · cited 1×
“For downloaded health-related apps, about half of users give up because of the amount of time taken to enter data, loss of interest, hidden costs, challenges with understanding how to use them, and concerns about data-sharing (11).”
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684 · cited 1×
“Glucose-based outcomes such as ambulatory glucose profiles (which show a patient’s daily glucose and insulin patterns, including time in the target range and a graphic representation of excursions out of that range) and glucose management indicators using CGM data are likely to have more impact for clinicians and peop…”
BackgroundHou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411 · cited 1×
“These A1C findings were similar to average A1C decreases (compared to controls) in randomized controlled trials of diabetes mobile apps noted elsewhere (8,9).”
ResultBonoto, B. C., de Araújo, V. E., Godói, I. P., de Lemos, L. L. P., Godman, B., Bennie, M., Diniz, L. M., & Junior, A. A. G. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6309 · Cited by 294 · cited 1×
“These A1C findings were similar to average A1C decreases (compared to controls) in randomized controlled trials of diabetes mobile apps noted elsewhere (8,9).”
ResultThe value of mHealth for managing chronic conditions
Agnihothri, S., Cui, L., Delasay, M., & Rajan, B. (2020) · Health Care Management Science · doi:10.1007/s10729-018-9458-2 · Cited by 96
Diabetes and technology in 2030: a utopian or dystopian future?
Kerr, D., Axelrod, C., Hoppe, C., & Klonoff, D. C. (2018) · Diabetic Medicine · doi:10.1111/dme.13586 · Cited by 35 · cited 1×
“What Is Digital Health? New digital technologies, including wearable and implanted sensors and effectors, comprise part of a digital ecosystem of data-driven tools that can link people with diabetes and their care teams, enabling precision management of diabetes (2).”
BackgroundSelf-citation
Cited by
Cranston, I., Jamdade, V., Liao, B., & Newson, R. S. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02478-1 · Cited by 37
“…hypoglycemic events), result in better adherence, provide decision support by allowing people with diabetes and their health care providers to look at trends over time, improve the well-being of the person with diabetes, and reduce disease-related burden on the person with diabetes [18, 54, 55].”
Diez Alvarez, S., Fellas, A., Wynne, K., Santos, D., Sculley, D., Acharya, S., Navathe, P., Gironès, X., & Coda, A. (2024) · JMIR mhealth and uhealth · doi:10.2196/54826 · Cited by 15
Complementarity of Digital Health and Peer Support: “This Is What’s Coming”
Tang, P. Y., Duni, J., Peeples, M. M., Kowitt, S. D., Bhushan, N. L., Sokol, R. L., & Fisher, E. B. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.646963 · Cited by 11
“People with diabetes, clinicians, investors, and techdevelopers all seem to recognize the promise of digital health in diabetes care, and regulators are encouraging growth in this field by lowering barriers to accessing new technologies (56).”
Background
Metadata
- Authors
- Kerr, D., King, F., & Klonoff, D. C.
- Venue
- Diabetes Spectrum
- Publisher
- American Diabetes Association
- Published
- 2019-08-01
- Volume
- 32
- Issue
- 3
- Pages
- 226-230
- ISSN
- 1040-9165 (ISSN-L)
- 1944-7353
- OpenAlex
- W2968509865
- Cited by
- 37
- References
- 6
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Digital Health Interventions for Diabetes: Everything to Gain and Nothing to Lose. https://app.cochat.ai/papers/10.2337/ds18-0085
- The paper
- Kerr, D., King, F., & Klonoff, D. C. (2019). Digital Health Interventions for Diabetes: Everything to Gain and Nothing to Lose. Diabetes Spectrum. https://doi.org/10.2337/ds18-0085
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.